Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a ...

The over-the-counter antihistamine works against a range of respiratory infections, including Covid, flu and RSV, according ...

An over-the-counter nasal spray antihistamine reduced rates of COVID-19 infections and common colds in a midstage trial, ...

The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease ...

The U.S. regulator has signed off on Corstasis Therapeutics’ Enbumyst to relieve the edema associated with congestive heart ...

Azelastine nasal spray was associated with a reduced risk for SARS-CoV-2 infection, according to the results of a phase 2 ...

Researchers have found in a new study that azelastine nasal spray may help reduce the risk of SARS-CoV-2 infection.

Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

A phase 2 study shows that azelastine nasal spray lowered coronavirus infection rates to 2.2% compared to 6.7%, researchers ...

COVID-19 most often enters the body through the nose and throat, where the virus first settles and begins to multiply ...

Nevada-based Corstasis Therapeutics (Corstasis) has announced FDA’s approval of its bumetanide nasal spray, Enbumyst, for the ...

A single dose of neffy epinephrine nasal spray resulted in successful treatment of anaphylaxis symptoms during oral food ...